Lorenzo Caciagli1, Andrea Bernasconi1, Samuel Wiebe1, Matthias J Koepp1, Neda Bernasconi1, Boris C Bernhardt2. 1. From the Neuroimaging of Epilepsy Laboratory (L.C., A.B., N.B., B.C.B.) and Multimodal Imaging and Connectome Analysis Laboratory (B.C.B.), Montreal Neurological Institute and Hospital, McGill University; Department of Clinical Neurosciences (S.W.), University of Calgary, Canada; and Department of Clinical and Experimental Epilepsy (L.C., M.J.K.), UCL Institute of Neurology, London, UK. 2. From the Neuroimaging of Epilepsy Laboratory (L.C., A.B., N.B., B.C.B.) and Multimodal Imaging and Connectome Analysis Laboratory (B.C.B.), Montreal Neurological Institute and Hospital, McGill University; Department of Clinical Neurosciences (S.W.), University of Calgary, Canada; and Department of Clinical and Experimental Epilepsy (L.C., M.J.K.), UCL Institute of Neurology, London, UK. boris.bernhardt@mcgill.ca.
Abstract
OBJECTIVE: It remains unclear whether drug-resistant temporal lobe epilepsy (TLE) is associated with cumulative brain damage, with no expert consensus and no quantitative syntheses of the available evidence. METHODS: We conducted a systematic review and meta-analysis of MRI studies on progressive atrophy, searching PubMed and Ovid MEDLINE databases for cross-sectional and longitudinal quantitative MRI studies on drug-resistant TLE. RESULTS: We screened 2,976 records and assessed eligibility of 248 full-text articles. Forty-two articles met the inclusion criteria for quantitative evaluation. We observed a predominance of cross-sectional studies, use of different clinical indices of progression, and high heterogeneity in age-control procedures. Meta-analysis of 18/1 cross-sectional/longitudinal studies on hippocampal atrophy (n = 979 patients) yielded a pooled effect size of r = -0.42 for ipsilateral atrophy related to epilepsy duration (95% confidence interval [CI] -0.51 to -0.32; p < 0.0001; I2 = 65.22%) and r = -0.35 related to seizure frequency (95% CI -0.47 to -0.22; p < 0.0001; I2 = 61.97%). Sensitivity analyses did not change the results. Narrative synthesis of 25/3 cross-sectional/longitudinal studies on whole brain atrophy (n = 1,504 patients) indicated that >80% of articles reported duration-related progression in extratemporal cortical and subcortical regions. Detailed analysis of study design features yielded low to moderate levels of evidence for progressive atrophy across studies, mainly due to dominance of cross-sectional over longitudinal investigations, use of diverse measures of seizure estimates, and absence of consistent age control procedures. CONCLUSIONS: While the neuroimaging literature is overall suggestive of progressive atrophy in drug-resistant TLE, published studies have employed rather weak designs to directly demonstrate it. Longitudinal multicohort studies are needed to unequivocally differentiate aging from disease progression.
OBJECTIVE: It remains unclear whether drug-resistant temporal lobe epilepsy (TLE) is associated with cumulative brain damage, with no expert consensus and no quantitative syntheses of the available evidence. METHODS: We conducted a systematic review and meta-analysis of MRI studies on progressive atrophy, searching PubMed and Ovid MEDLINE databases for cross-sectional and longitudinal quantitative MRI studies on drug-resistant TLE. RESULTS: We screened 2,976 records and assessed eligibility of 248 full-text articles. Forty-two articles met the inclusion criteria for quantitative evaluation. We observed a predominance of cross-sectional studies, use of different clinical indices of progression, and high heterogeneity in age-control procedures. Meta-analysis of 18/1 cross-sectional/longitudinal studies on hippocampal atrophy (n = 979 patients) yielded a pooled effect size of r = -0.42 for ipsilateral atrophy related to epilepsy duration (95% confidence interval [CI] -0.51 to -0.32; p < 0.0001; I2 = 65.22%) and r = -0.35 related to seizure frequency (95% CI -0.47 to -0.22; p < 0.0001; I2 = 61.97%). Sensitivity analyses did not change the results. Narrative synthesis of 25/3 cross-sectional/longitudinal studies on whole brain atrophy (n = 1,504 patients) indicated that >80% of articles reported duration-related progression in extratemporal cortical and subcortical regions. Detailed analysis of study design features yielded low to moderate levels of evidence for progressive atrophy across studies, mainly due to dominance of cross-sectional over longitudinal investigations, use of diverse measures of seizure estimates, and absence of consistent age control procedures. CONCLUSIONS: While the neuroimaging literature is overall suggestive of progressive atrophy in drug-resistant TLE, published studies have employed rather weak designs to directly demonstrate it. Longitudinal multicohort studies are needed to unequivocally differentiate aging from disease progression.
Authors: S S Keller; U C Wieshmann; C E Mackay; C E Denby; J Webb; N Roberts Journal: J Neurol Neurosurg Psychiatry Date: 2002-12 Impact factor: 10.154
Authors: H Jokeit; A Ebner; S Arnold; M Schüller; C Antke; Y Huang; H Steinmetz; R J Seitz; O W Witte Journal: J Neurol Date: 1999-10 Impact factor: 4.849
Authors: Nobuko Kemmotsu; Holly M Girard; Boris C Bernhardt; Leonardo Bonilha; Jack J Lin; Evelyn S Tecoma; Vicente J Iragui; Donald J Hagler; Eric Halgren; Carrie R McDonald Journal: Epilepsia Date: 2011-10-05 Impact factor: 5.864
Authors: Ana C Coan; Brunno M Campos; Clarissa L Yasuda; Bruno Y Kubota; Felipe Pg Bergo; Carlos Am Guerreiro; Fernando Cendes Journal: PLoS One Date: 2014-01-27 Impact factor: 3.240
Authors: Gyujoon Hwang; Veena A Nair; Jed Mathis; Cole J Cook; Rosaleena Mohanty; Gengyan Zhao; Neelima Tellapragada; Candida Ustine; Onyekachi O Nwoke; Charlene Rivera-Bonet; Megan Rozman; Linda Allen; Courtney Forseth; Dace N Almane; Peter Kraegel; Andrew Nencka; Elizabeth Felton; Aaron F Struck; Rasmus Birn; Rama Maganti; Lisa L Conant; Colin J Humphries; Bruce Hermann; Manoj Raghavan; Edgar A DeYoe; Jeffrey R Binder; Elizabeth Meyerand; Vivek Prabhakaran Journal: Brain Connect Date: 2019-03
Authors: Shahin Tavakol; Jessica Royer; Alexander J Lowe; Leonardo Bonilha; Joseph I Tracy; Graeme D Jackson; John S Duncan; Andrea Bernasconi; Neda Bernasconi; Boris C Bernhardt Journal: Epilepsia Date: 2019-03-19 Impact factor: 5.864
Authors: Rani A Sarkis; Scott McGinnis; Sara N Rushia; Suna Park; Emile E Ansari; Kim C Willment Journal: J Neurol Date: 2018-02-24 Impact factor: 4.849
Authors: Luke A Allen; Sjoerd B Vos; Rajesh Kumar; Jennifer A Ogren; Rebecca K Harper; Gavin P Winston; Simona Balestrini; Britta Wandschneider; Catherine A Scott; Sebsatien Ourselin; John S Duncan; Samden D Lhatoo; Ronald M Harper; Beate Diehl Journal: Epilepsia Date: 2019-03-14 Impact factor: 5.864
Authors: Dario J Englot; Hernan F J Gonzalez; Bryson B Reynolds; Peter E Konrad; Monica L Jacobs; John C Gore; Bennett A Landman; Victoria L Morgan Journal: Neurology Date: 2018-05-30 Impact factor: 9.910
Authors: Andre Altmann; Mina Ryten; Martina Di Nunzio; Teresa Ravizza; Daniele Tolomeo; Regina H Reynolds; Alyma Somani; Marco Bacigaluppi; Valentina Iori; Edoardo Micotti; Rossella Di Sapia; Milica Cerovic; Eleonora Palma; Gabriele Ruffolo; Juan A Botía; Julie Absil; Saud Alhusaini; Marina K M Alvim; Pia Auvinen; Nuria Bargallo; Emanuele Bartolini; Benjamin Bender; Felipe P G Bergo; Tauana Bernardes; Andrea Bernasconi; Neda Bernasconi; Boris C Bernhardt; Karen Blackmon; Barbara Braga; Maria Eugenia Caligiuri; Anna Calvo; Chad Carlson; Sarah J A Carr; Gianpiero L Cavalleri; Fernando Cendes; Jian Chen; Shuai Chen; Andrea Cherubini; Luis Concha; Philippe David; Norman Delanty; Chantal Depondt; Orrin Devinsky; Colin P Doherty; Martin Domin; Niels K Focke; Sonya Foley; Wendy Franca; Antonio Gambardella; Renzo Guerrini; Khalid Hamandi; Derrek P Hibar; Dmitry Isaev; Graeme D Jackson; Neda Jahanshad; Reetta Kälviäinen; Simon S Keller; Peter Kochunov; Raviteja Kotikalapudi; Magdalena A Kowalczyk; Ruben Kuzniecky; Patrick Kwan; Angelo Labate; Soenke Langner; Matteo Lenge; Min Liu; Pascal Martin; Mario Mascalchi; Stefano Meletti; Marcia E Morita-Sherman; Terence J O'Brien; Jose C Pariente; Mark P Richardson; Raul Rodriguez-Cruces; Christian Rummel; Taavi Saavalainen; Mira K Semmelroch; Mariasavina Severino; Pasquale Striano; Thomas Thesen; Rhys H Thomas; Manuela Tondelli; Domenico Tortora; Anna Elisabetta Vaudano; Lucy Vivash; Felix von Podewils; Jan Wagner; Bernd Weber; Roland Wiest; Clarissa L Yasuda; Guohao Zhang; Junsong Zhang; Costin Leu; Andreja Avbersek; Maria Thom; Christopher D Whelan; Paul Thompson; Carrie R McDonald; Annamaria Vezzani; Sanjay M Sisodiya Journal: Neuropathol Appl Neurobiol Date: 2021-09-05 Impact factor: 8.090